Two patients with ovarian cancer refractory to cisplatin-based chemotherapy managed by a new combination chemotherapy with irinotecan hydrochloride and mitomycin-C

Author:

Takizawa Ken,Satow Yoh-ichi,Kato Yoshio,Kawana Takashi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Reference9 articles.

1. Shimizu Y, Umezawa S, Takeshima N, Hirai Y, Fujimoto I, Yamauchi K, Hasumi K. Chemotherapy of ovarian cancer patients with a combination of low-dose consecutive CDDP and cyclophosphamide. Jpn J Obstet Gynecol 1993;45:444–450.

2. Silverberg E, Boring C, Squires TS. Cancer statistics 1900. CA Cancer J Clin 1990;40:9–26.

3. Serov SF, Scully RE, Solvin LH. International histological classification of tumors, No 9; histological typing of ovarian tumors. World Health Organization, Geneva 1973;37–38.

4. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207–214.

5. Oncology Committee of the International Federation of Gynecology and Obstetrics. Changes in definitions of clinical staging for carcinoma of the cervix and ovary; International Federation of Gynecology and Obstetrics. Am J Obstet Gynecol 1987;156:263–264.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3